chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pre-teen presented for routine camp physical (Camp in July). Cleared with NKDA, Zyrtec prn for spring seasonal allergies, Liquid motrin prn musculoskeletal growth pain (89lb and 65in), no PMH.  Can eat eggs just doesn't like, can drink milk, eat beef, etc.....no food allergies.  He received routine Tdap and first MEN vaccine about 0954am.  They went home and mom gave him oral motrin for body aches (first time using pill form Motrin).  Mom advised no PE that day (missed as getting vaccines), had normal food/lunch, no change in detergents, soaps, etc.... He reports about 3:15pm his chest began to itch.  Home at 3:30, mom noted chest and back with multiple red and blotchy welts as if bitten by a bug. He took a shower and condition worsened - now on face, neck, back, chest, abdomen, groin area.  Teen had no other systemic symptoms, SOB, difficulty swallowing, breathing, etc. Mom called HCP and teen taken to ER where given oral benadryl....mom reports it was not effective after 30 min so ER MD prescribed prednisolone.  Again no response or easing of reaction (but not worse) so MD sent home to continue use of Benadryl and Steroids.  On way home, mom stopped for meds, picked up some food, but teen was sleeping and once home difficult to arouse.  Mom said he "blacked out", was hot and sweaty but had awakened by time ambulance arrived.  She transported to hospital by POV where MD again gave 2nd dose of Benadryl as due, an IV and monitored. Welts were easing but now visible on legs.  Mom said took a couple of days <2 to fully resolve. Mom said 2nd MD at hospital advised reaction most likely due to the vaccines and his "blackout" could have been a hypoglycemic event.
I had chills, full body muscle aches that were intense. Had a fever of 102. Headache , fatigue, nausea. Took Tylenol and ibuprofen, was gone about 36 hours later
states that 12 days after having second dose he started having leg pain and went to the hospital where he was dx with blood clots in left leg.  He states both legs were swelling and developed wounds.
Discharge Provider: DO Primary Care Provider at Discharge: MD  Admission Date: 9/29/2022 Discharge Date: 10/3/2022    HOSPITAL COURSE: Patient is a 65 y.o. female with past medical history significant for breast cancer, asthma, hypertension, GERD, and anxiety, who presented to the ED with a chief complaint of right-sided abdominal pain associated with diarrhea. Recently completed course of antibiotics in August for colitis. Also with dry cough and sore throat with daughter recently testing positive for COVID. In the ED, vitals significant for fever, hypoxia which improved on 2L. Labs showed WBC count of 15.62, CRP 256, Cr elevated at 1.65. COVID-19 PCR positive. Chest x-ray with no acute findings.  CT abdomen and pelvis was reviewed with colon wall thickening at the level of the splenic flexure extending throughout the left colon with surrounding inflammatory change consistent with colitis.  Patient was given 1 L normal saline bolus, Decadron 6 mg, morphine 4 mg, and Zofran while in the ED. Patient will be admitted to hospital medicine for further workup and treatment of sepsis secondary to colitis and COVID-19.   On admission, she was started on Remdesivir and continued on decadron for treatment of COVID. She was started on Rocephin and Flagyl for treatment of colitis. GI was consulted and recommended to stop antibiotics with negative enteric pathogens. Planning outpatient colonoscopy 11/8. Her diet was advanced and tolerated. Her AKI improved with IVF hydration. Her oxygen was weaned off. She was discharged in stable condition.
Had stroke.  Hospitalized x 5 days.  Diagnosed with carotid clot.
Sore throat; Coughing; Glucose is high (170); Phlegm; Horse voice; Headache; Temperature of 99.3 degree F; This spontaneous case was reported by a patient and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), COUGH (Coughing), BLOOD GLUCOSE INCREASED (Glucose is high (170)), PRODUCTIVE COUGH (Phlegm) and DYSPHONIA (Horse voice) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form(s). On 31-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat), COUGH (Coughing), BLOOD GLUCOSE INCREASED (Glucose is high (170)), PRODUCTIVE COUGH (Phlegm), DYSPHONIA (Horse voice), HEADACHE (Headache) and PYREXIA (Temperature of 99.3 degree F). At the time of the report, OROPHARYNGEAL PAIN (Sore throat), COUGH (Coughing), BLOOD GLUCOSE INCREASED (Glucose is high (170)), PRODUCTIVE COUGH (Phlegm), DYSPHONIA (Horse voice), HEADACHE (Headache) and PYREXIA (Temperature of 99.3 degree F) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Mar-2021, Blood glucose: 170 High. On 31-Mar-2021, Body temperature: 99.3 DF.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient received cough drop (halls).
Suffered skin lesions in breast and chest and severe ear pain and was diagnosed with shingles and post herpetic neuralgia; Suffered skin lesions in breast and chest and severe ear pain and was diagnosed with shingles and post herpetic neuralgia; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding medical history, concurrent conditions, or concomitant medications. In or around 03-NOV-2009, the patient was vaccinated (inoculated) with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified) for routine health maintenance and for its intended purpose: the prevention of shingles (prophylaxis). Shortly after receiving zoster vaccine live (ZOSTAVAX) the patient suffered skin lesions in breast and chest and severe ear pain and was diagnosed with shingles and post herpetic neuralgia. As a direct and proximate result of the patient's use of the vaccine live (ZOSTAVAX) vaccine, the patient had resulted in physical limitations do not present prior to using the product. Also, experienced mental and emotional distress due to resulting physical limitations and seriousness condition. As a result of the manufacture, marketing, advertising, promotion, distribution and sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment, and injury. As a direct and proximate results of defendant's conduct, the patient suffered and incurred damages, including medical expenses; the loss of accumulation; and other economic and non-economic damages. The outcome of the event s was reported as not recovered. Therefore, the causality for the event was related to zoster vaccine live (ZOSTAVAX).  The lawyer considered the shingles and post herpetic neuralgia to be disability events.
No antibodies to COVID 19 in lab test done 5/20/2021. 3rd dose of COVID-19 Moderna vaccine administered 6/1/2021. Titers planned for 4-6 weeks post 3rd vaccine.
Initial report was received from a health care professional on 28 September 2012. An 84-year-old male patient, whose medical history and concomitant medications were not reported, had received FLUZONE HD vaccine, (lot number: U4490AA site of administration was not reported) intramuscularly on 23 September 2012. It was reported that on 23 September 2012, after receiving FLUZONE HD vaccine, the patient experienced "bumps/rash" all over body and patient had self-treated with BENADRYL which had provided only slight relief. The laboratory investigations were not reported. As of 28 September 2012, the patient not recovered from the event. Follow-up information was received 19 November 2012 from a health care professional. Based upon new information received, this case now meets seriousness criteria, and has been upgraded from nonserious to serious. The patient received FLUZONE HIGH-DOSE in the left arm. According to the reporter, the patient had a rash and blisters all over. BENADRYL was the only medication prescribed as corrective treatment. The patient had no illness at the time of vaccination and no other medications reported on "VAR" form. The patient recovered around 30 September 2012. Documents held by sender: None.
Severe Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of VOMITING (Severe Vomiting) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension (High Blood Pressure), Cholesterol, Hernia and Anxiety. Concomitant products included CITALOPRAM for Anxiety, ATENOLOL, AMLODIPINE and POTASSIUM CHLORIDE for Blood pressure high, ROSUVASTATIN for Cholesterol, PANTOPRAZOLE for Hernia, VITAMIN D3 for Supplementation therapy.   In May 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. In May 2021, the patient experienced VOMITING (Severe Vomiting). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and ASPIRIN [ACETYLSALICYLIC ACID] for Adverse event, at an unspecified dose and frequency. At the time of the report, VOMITING (Severe Vomiting) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Apr-2020, SARS-CoV-2 test: positive (Positive) positive.         Patient was treated for nausea and discharged home   This case was linked to MOD-2021-089390 (Patient Link).   Reporter did not allow further contact
Around 5pm patient started having heavy feeling limbs, she went to bed and that night felt like her muscles would all clench up at once on and off throughout the night. The next morning she felt muscle aches and tiredness but the muscle spasms stopped. She took aspirin and felt back to normal later in the day.
sore at the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 27th April 2022, the patient received the 1st dose of Shingrix (intramuscular). On 27th April 2022, 1 hr after receiving Shingrix, the patient experienced injection site pain. On 1st May 2022, the outcome of the injection site pain was recovered/resolved.   It was unknown if the reporter considered the injection site pain to be related to Shingrix.     Additional Information: GSK receipt date: 3-May-2022 Reporter's comment: The patient reported that she received a dose of Shingrix in left arm and about an hour after receiving the Shingrix vaccine she had a sore arm at the injection site. The reporter did not gave permission to contact health care professional. Did not consent to follow-up.
COVID-19 Vaccine EUA; Got vaccine around 5:30pm 2/11/21. About half hour later, face felt a little weird like when you are coming off of novocaine at the dentist. Tip of nose & cheeks sort of numb. Head felt heavy/pressure. Didn't think much of it, but still feeling it the next day (19 hours after shot). Face just feels funny. I feel the same way when I am around a lot of balloons or rubber tires since I have a latex allergy. Sort of affecting my vision as well, seems to go out of focus every now and then.
PATIENT COMPLAINING OF VACCINE BEING GIVEN TOO UP TO THE SHOULDER BONE, PAIN, HARD TIME LIFTING THE ARM
30MAR92 pt recvd 1st dose of Engerix-B & had immed tightness in chest, tingling in mouth & gums, numbness in face & a severe h/a;
This spontaneous report was received from a female consumer in her 60's, concerning herself. The patient's concurrent condition included economic problems. Patients' pertinent medical history, drug reaction/allergies or concomitant information were not reported. On an unspecified date in 2016, the patient was vaccinated with ZOSTAVAX (route, dosage schedule, lot # and expiration date were not reported). On an unspecified date in 2016 (reported as "for many months"), the patient experienced chronic dysphonia. The patient's outcome for her dysphonia was unknown at the reporting time. The reporter did not provided the causality assessment between the event and the suspect therapy. Additional information has been requested.
Myalgia  chills Narrative: missed time from work day following  second dose due to above symptoms
The patient experienced a generalized seizure  lasting approximately 30 seconds with urinary incontinence. The patient remained unconscious for approximately 1 min post seizure and remained in a post-ictal state for approximately 3 minutes  until normalization of mental status. The patient was transported to the hospital via ambulance for further evaluation.
Pt received a full dose (.5ml) of Moderna vaccine as a first booster to their primary J&J series. They should have received a half dose (.25ml).
Information has been received from a registered nurse, concerning an adult female "in her forties" with a history of two episodes of severe chickenpox, who on 06-MAY-2008 was vaccinated with zoster vaccine live (Oka/Merck) (lot # dose and route not specified). On 07-MAY-2008 the patient developed "blisters" on her chest, and contacted the physician's office by telephone. At the time of this report, the outcome of the event was not recovered. No further information was available. Additional information has been requested.
My daughters arm swelled up and her legs were in pain right after  the shot , she was told that the batch of medication she was given was a bad batch and that she was the 4th child with these side effects.
w/in 48 hrs devel t104, mild convuls described as chattering teeth shivering couldn't hold thermometer; sore throat; treated by parent w/ice packs, ASA, APAP, Ibuprofen; states arm numb p/shot; today arm sl sowllen & sore; not seen by MD;
Soreness in arm for 3 days. Sore legs while walking 6-7 hours post injection.
After receiving the vaccine sometime in the afternoon on Monday, June 26, the patient became symptomatic the following morning. She reported intense body aches, chills, and a fever of 101.6 F. The injection site was red and puffy. She took ADVIL for the aches. Symptoms continued through June 27, but had resolved by June 28th. She experienced similar symptoms with the first dose 3 months prior, except there were no chills the first time around.
Agency staff administering  flu and covid vaccines. Father was to receive covid vaccine and daughter was being fussy so wanted her to receive flu vaccine first. Agency staff grabbed covid vaccine and gave to 4 yr old in leg instead of giving the flu vaccine. Covid vaccine is for 12 + years of age.
Fever and chills the night after the vaccine. Followed by prolonged stiffness and soreness of all joints, especially knee and ankle joints. Periodic headaches and cloudy head. The sore joints have persisted for at least 9 days, and were actually noticed prior to the 2nd dose of the vaccine.
Swelling and redness in and around injection site, and itchiness.  Symptoms appeared approximately 16 days after vaccine administered.  Initial reaction to injection consisted of swelling, some redness, and tenderness which lasted about 3 days after the vaccination, then, no symptoms until those reported above.
Very bad ringing in left ear has not stopped. Strong taste of metal in my mouth that has not stopped.  Dull headache.
Patient given vaccine at age 11 due to mom inputting incorrect dob on vaccine convent form. No adverse reactions noted during the waiting period after vaccine given.
Information has been received from a consumer concerning her husband who on 04-MAR-2008 noticed two blisters on his arm after his daughter was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) and was diagnosed with shingles. He was not sure if it was related to his daughter' case of shingles. No further information was given. There was no product quality complaint. Additional information has been requested.
pt c/o sore arm when elevating arm above shoulder lever;no rash, swelling, discoloration, not hot to touch;
This spontaneous report was received from a physician refers to a male patient in his late 60s or early 70s, who on an unknown date, was vaccinated once with a 0.65 ml dose of ZOSTAVAX (route and lot number not reported). No other co-suspects were reported. The physician reported that the patient came to the office on an unknown date and got an unspecified flu vaccine and a few days later he developed shingles on an unspecified date. No treatment information was reported. No lab diagnostics studies were performed. At the time of the report, the patient had not recovered. The patient sought unspecified medical attention. The relatedness for patient developed shingles was unknown for ZOSTAVAX. Additional information is not expected.
Associated with a LTC facility.   experienced dyspnea, cough, wheezing and fever Hospitalized
This spontaneous report was received from a licensed practical nurse, referring to a 18 year old, female patient. The patient's medical history, concurrent conditions and drug reactions/allergies were not reported. On unknown dates the patient was vaccinated with the three dose series of GARDASIL (dose, route, lot # and expiration date were not reported). Then, on 28-JUL-2015, the patient was vaccinated with an additional dose of GARDASIL 9 by intramuscular route in the left arm (reported as LD), lot # K026247 (expiration date was not reported), because a company representative mistakenly told that it was the Centers for Disease Control and Prevention (CDC) recommendation. No concomitant medications were reported. No adverse effects were reported. No product quality complaint was involved. This is one of several reports received from the same source. Additional information is not expected as all scheduled follow up information has been received.
This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received the first dose of the Moderna vaccine while under 18 years of age) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received the first dose of the Moderna vaccine while under 18 years of age). On 26-May-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Received the first dose of the Moderna vaccine while under 18 years of age) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided. Treatment information was not provided.
The pt is a Pulmonologist. He was reportedly "healthy". "Test performed before and during the study showed no signs that the participants hand Lyme disease". The pt received 2 doses of Lymerix on unspecified dates. Within 24 hours of 2nd dose, he developed "severe swelling, redness and pain in his fingers". He also developed "acute disabling small and large joint symmetrical synovitis". A dx of "arthritis in his hands" was made. He also experienced "pain throughout his body" and myalgia. He was unable to work for 3 days. He was treated with "moderate doses of NSAIDS (NOS)". However, the abstract indicated that he recovered without sequelae within 4 or 5 days. The guest physician stated, "And we have no reason to believe that it was anything but the vaccine involved in the development of the arthritis." He further stated, "We believe that the immune response to OspA is resulting in an auto reactive response." F/U acute symetrical polyarthritis, additional information was provided by the primary author. The pt rec'd his 1st SC injection of LYMerix (lot LY120B9)on 9/2/99, no adverse experiences occurred following this injection. He rec'd his 2nd SC injection of LYMErix (lot LY123B9) on 10/1/99, he experienced pain throughout his body. Two days post vaccine on 10/2/99 he developed severe swelling. A dx of acute symmetrical polyarthritis was made. The primary author reported that the polyarthritis resolved after 5 days. Acute symmetrical polyarthritis does not meet icm serious criteria.
My daughter got the vaccines, we left and went to the store, 20 min later my daughter fainted. Turn completely pale and her lips starting turning blue. She was in and out for about 2 mins. I took her back to see the dr and he was surprise that the nurse that gave the vaccine didn?t have us wait since it was her first time getting the meningitis vaccines.
Mom woke up him up for school at 6am and noted that his legs looked "red and patchy", she looked further and found rash on his arms and left side of his face. Left side of face was swollen.  Right knee and thigh notable swollen with "pitting edema". Mom has a picture on her phone. He feels like he slept well and wasn't itching. He denies that his throat felt swollen, fuzzy, or having trouble breathing. He does say that he felt itchy and tired. Mom gave BENADRYL at 7:30am. He doesn't feel tired. Feels itchy. Appetite decreasd. No headache.
4 days p/immun devel fever 101 to 102 5 days p/immun or 24 hrs  p/onset of fever; screamed incessantly; takento ER; dx sepsis due to E. Coli, urinary infection-E. coli also DIC, low platlet, pt elevated PTT elevated;
Dizziness, lightheadedness, wheezing, chills, headache, body aches, sore arm - 6 to 8 hours Arm swelling, hard lump, redness near injection site - began on day February 15. Hardness lasted five days, redness lasted 13 days Sleep disturbances - difficulty getting to sleep, waking in middle of night with feeling of disorientation - began on February 15 and lasted for four nights. Eye pain with feeling of object in eye and red, itchy eyelids. Began February 17 and recurred intermittently for six days.
Periorbital edema, intense itching, drooling/lethargy. Oral Pred 15mg given without improvement. EPIPEN Jr 0.15mg administered.